Heart Failure

This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant  or a left ventricular assist device (LVAD).

cyanosis, cyantosis COVID-positive infant.
News | Coronavirus (COVID-19)
COVID-19 Can Impact Hearts in Young Children

December 2, 2020 — A 2-month-old infant diagnosed with COVID-19 (SARS-CoV-2) experienced reversible myocardial injury ...

Home December 02, 2020
Home
CMS coverage changes effective as of Dec. 2, 2020 will open up the use of LVADs to more Medicare patients, including use of the HeartWare and HeartMate ventricular assist devices.
News | Heart Failure
CMS Updates Coverage Policies for Artificial Hearts and Ventricular Assist Devices

December 2, 2020 — The Centers for Medicare and Medicaid Services (CMS) finalized updates to Medicare coverage policies ...

Home December 02, 2020
Home
Results from study of more than 14,000 patients across the United States show the heavy impact of cardiac disease on hospitalized COVID patients. COVID-19 patients with cardiovascular diseases have in-hospital mortality rates of between 25 to 38 percent. #AHA #AHA20 #AHA2020 #COVID19 #Coronavirus #SARSCoV2
News | Coronavirus (COVID-19) | Dave Fornell, Editor
COVID-19 Patients With Cardiovascular Disease Have In-hospital Mortality Rates of 25 to 38 Percent

November 18, 2020 — A late-breaking study at the 2020 American Heart Association (AHA) Scientific Sessions showed nearly ...

Home November 18, 2020
Home
Some of the device technologies discussed in the TCT 2020 late-breaking trial sessions. Top left, the  Medtronic Resolute Onyx stent was the first stent to receive FDA clearance for short duration dual-antiplatelet therapy, which was a big topic and subject of several sessions. Lower left, the Keystone TriGuard 3 TAVR embolic protection device did not demonstrate superiority over TAVR without use of embolic protection. Top right, the Abbott MitraClip. Acurate neo TAVR valve. #TCTconnect #TCT2020
Feature | TCT | Dave Fornell, Editor
Top 10 Takeaways on Interventional Technologies at TCT 2020

Here are some of the key takeaways from the late-breaking interventional cardiology and structural heart trials ...

Home October 29, 2020
Home
Videos | Heart Failure
VIDEO: Use of MitraClip as a Bridge to Heart Transplant

The late-breaking MitraBridge Study was presented at Transcatheter Cardiovascular Therapeutics (TCT) 2020 meeting showed ...

Home October 16, 2020
Home
Effect of COVID-19 on Cardiology Highlighted in Research at ACC Quality Summit. Research examines telehealth, healthcare disparities, as well as impacts on interventional cardiology, patient-centered care.
News | Coronavirus (COVID-19)
Effect of COVID-19 on Cardiology Highlighted in Research at ACC Quality Summit

October 14, 2020 — American College of Cardiology (ACC) Quality Summit virtual meeting Oct. 8-9, 2020, featured several ...

Home October 14, 2020
Home
Flexible electronics have been developed to implant in patients to constantly monitor their cardiac condition.
Feature | Udi Nussinovitch M.D., Ph.D.
What is New in Cardiology? A Review of All Major Emerging Technologies for Heart Diseases

This is an overview of some of the biggest cardiology technology advances. These innovations are covered in more detail ...

Home October 09, 2020
Home
Chest X-ray of a congestive heart failure patient, showing fluid in the lower portions of the lungs and an enlarged heart. Getty Images
News | Heart Failure
ACC and Novartis Collaborate to Optimize Heart Failure Care With TRANSFORM Study

October 5, 2020 — The American College of Cardiology (ACC) says heart failure (HF) is a cardiovascular epidemic. In ...

Home October 05, 2020
Home
The Cardiac Dimensions Carillon Mitral Contour System, a transcatheter device used to treat functional mitral regurgitation (FMR) in patients with heart failure.
News | Heart Valve Technology
Cardiac Dimensions Announces $17.5 Million in Financing to Accelerate Sales Expansion of The Carillon Mitral Contour System

October 2, 2020 — Cardiac Dimensions announced the company has closed a $17.5 million Series C financing that will be ...

Home October 02, 2020
Home
The Optimizer Smart System is a pacemaker-like device that improves heart function and reduces debilitating symptoms associated with the disease, including fatigue and shortness of breath.
News | Heart Failure
Allegheny General Hospital Cardiologists First in the Region to Use Novel Implantable Device to Treat Heart Failure

September 23, 2020 – A team of cardiologists at Allegheny General Hospital (AGH), part of Allegheny Health Network (AHN) ...

Home September 23, 2020
Home
The BRACE CORONA trial presented at ESC Congress 2020 is the First Randomized Trial Backs Safety of ACE and ARB Heart Drugs in COVID-19 Patients.
News | Coronavirus (COVID-19)
First Randomized Trial Backs Safety of ACE and ARB Heart Drugs in COVID-19 Patients

September 8, 2020 - Heart patients hospitalized with COVID-19 (SARS-CoV-2) can safely continue taking angiotensin ...

Home September 08, 2020
Home
Navin Kapur, M.D., FAHA, FACC, FSCAI, executive director, The CardioVascular Center for Research and Innovation (CVCRI), explains the concpet of the Door-to-Unloading (DTU) Trial he is heading, one of several innovations at Tufts Medical Center in Boston. Kapur is also director, Acute Mechanical Circulatory Support Program; director, interventional research laboratories; director of Cardiac Biology Research Center, Molecular Cardiology Research Institute (MCRI), Tufts Medical Center. Photo by Dave Fornell
Feature | Tufts Medical Center | Dave Fornell, Editor
Cardiovascular Innovation at Tufts Medical Center

The cardiology program at Tufts Medical Center in Boston is internationally recognized for being on the forefront of ...

Home August 21, 2020
Home
The Medtronic Heartware and Abbott Heartmate 3 LVADs and others currently cleared by the FDA might be easier to use in Medicare advanced heart failure patients under new guidelines proposed by CMS. Photo by Dave Fornell
Feature | Heart Failure | Dave Fornell, Editor
CMS Proposes Coverage Updates for Artificial Hearts and Ventricular Assist Devices

August 21, 2020 — The U.S. Centers for Medicare and Medicaid Services (CMS) proposed updates to coverage policies for to ...

Home August 21, 2020
Home
Photo of Eyes Predicts Death and Readmission in Heart Failure Patients. Getty Images.
News | Heart Failure
Photo of Eyes Predicts Death and Readmission in Heart Failure Patients

 


August 17, 2020 — Pupil size predicts death and hospital readmission in patients with heart failure, according to r ...

Home August 17, 2020
Home
Wearable Sensors and AI App Used to Remotely Monitor Heart Failure Patients in NorthShore Health System. Carnegie Mellon University, Northshore and physIQ launch Study of monitoring technology for high-risk cardiac and surgical patients.
News | Remote Monitoring
Wearable Sensors and AI App Used to Remotely Monitor Heart Failure Patients in NorthShore Health System

August 5, 2020 – NorthShore University HealthSystem , Carnegie Mellon University and physIQ are collaborating on a multi ...

Home August 05, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now